Physician-reported patient involvement and treatment decisions in first-line ovarian cancer in the USA and Europe.

ABSTRACT:

Objectives

Real-world data evaluating how approvals of novel treatment regimens for ovarian cancer have impacted the treatment paradigm, including first-line maintenance, are lacking. This analysis aimed to describe treatment patterns for advanced epithelial ovarian cancer in Europe and the USA in the first-line maintenance setting. Patient characteristics, biomarker testing rates, and drivers of treatment choice were also evaluated.

Methods

A retrospective chart review study of electronic medical records in Europe and the USA was conducted for patients diagnosed with epithelial ovarian cancer (June 1, 2017-May 31, 2020), in line with Healthcare Market Research guidelines. Eligible physicians extracted data from electronic medical records by completing standardized patient r

SUBMITTER: Moore KN 

PROVIDER: S-EPMC11671897 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature